Consumption of Fruitflow^® lowers blood pressure in pre-hypertensive males: a randomised, placebo controlled, double blind, cross-over study

References

• Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. 2003. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett. 555:597–600.
   PubMed Web of Science ®Google Scholar
• Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. 1991. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 324:1098–1104.
   PubMed Web of Science ®Google Scholar
• Biswas D, Uddin MM, Dizdarevic LL, Jorgensen A, Duttaroy AK. 2014. Inhibition of angiotensin-converting enzyme by aqueous extract of tomato. Eur J Nutr. 53:1699–1706.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JP, Rothstein HR. 2010. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 1:97–111.
   PubMed Web of Science ®Google Scholar
• Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. 2004. Activation of the systemic and adipose renin–angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 287:R943–R949.
   PubMed Web of Science ®Google Scholar
• Castrop H. 2015. A role for AT1 receptor-associated proteins in blood pressure regulation. Curr Opin Pharmacol. 21:43–47.
   PubMed Web of Science ®Google Scholar
• Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, Lara J. 2017. Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis. Atherosclerosis. 257:100–108.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, et al. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Davis JO, Freeman RH. 1976. Mechanisms regulating renin release. Physiol Rev. 56:1–56.
   PubMed Web of Science ®Google Scholar
• Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, et al. 2005. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 23:7–17.
   PubMed Web of Science ®Google Scholar
• Edwards LJ, Simpson SL. 2014. An analysis of 24-h ambulatory blood pressure monitoring data using orthonormal polynomials in the linear mixed model. Blood Press Monit. 19:153–163.
   PubMed Web of Science ®Google Scholar
• Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ. 2005. Rethinking the “diseases of affluence” paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2:e133.
   PubMed Web of Science ®Google Scholar
• Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. 2003. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 21:2281–2286.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Tsuda T, Berk BC, Alexander RW. 1989. Angiotensin II stimulation of vascular smooth muscle cells. Secondary signalling mechanisms. Am J Hypertens. 2:659–665.
   PubMed Web of Science ®Google Scholar
• Guerrero L, Castillo J, Quinones M, Garcia-Vallve S, Arola L, Pujadas G, Muguerza B. 2012. Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS One. 7:e49493.
   PubMed Web of Science ®Google Scholar
• Hackl LP, Cuttle G, Dovichi SS, Lima-Landman MT, Nicolau M. 2002. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to Bradykinin and angiotensin I. Pharmacology. 65:182–186.
   PubMed Web of Science ®Google Scholar
• Hall JE. 1991. The renin–angiotensin system: renal actions and blood pressure regulation. Compr Ther. 17:8–17.
   PubMedGoogle Scholar
• Huang WY, Davidge ST, Wu J. 2013. Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment. Crit Rev Food Sci Nutr. 53:615–630.
   PubMed Web of Science ®Google Scholar
• Kim H, Andrade FC. 2016. Diagnostic status of hypertension on the adherence to the Dietary Approaches to Stop Hypertension (DASH) diet. Prev Med Rep. 4:525–531.
   PubMedGoogle Scholar
• Kowala MC, Grove RI, Aberg G. 1994. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis. 108:61–72.
   PubMed Web of Science ®Google Scholar
• Larson AJ, Symons JD, Jalili T. 2012. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr. J3:39–46.
   Google Scholar
• Law MR, Morris JK, Wald NJ. 2009. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 338:b1665.
   PubMed Web of Science ®Google Scholar
• Li GH, Liu H, Shi YH, Le GW. 2005. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. J Pharm Biomed Anal. 37:219–224.
   PubMed Web of Science ®Google Scholar
• O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, et al. 2013. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 31:1731–1768.
   PubMed Web of Science ®Google Scholar
• O’Kennedy N, Crosbie L, Song HJ, Zhang X, Horgan G, Duttaroy AK. 2017. A randomised controlled trial comparing a dietary antiplatelet, the water-soluble tomato extract Fruitflow, with 75 mg aspirin in healthy subjects. Eur J Clin Nutr. 71:723–730.
   PubMed Web of Science ®Google Scholar
• O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK. 2006. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr. 84:570–579.
   PubMed Web of Science ®Google Scholar
• O’Kennedy N, Raederstorff D, Duttaroy AK. 2016. Fruitflow(R): the first European Food Safety Authority-approved natural cardio-protective functional ingredient. Eur J Nutr. 56:461–482.
   PubMed Web of Science ®Google Scholar
• Palomo I, Fuentes E, Padro T, Badimon L. 2012. Platelets and atherogenesis: platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med. 3:577–584.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al. 1992. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The save Investigators. N Engl J Med. 327:669–677.
   PubMed Web of Science ®Google Scholar
• Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, Andrica F, Ahmed A, Aronow WS, Muntner P, et al. 2016. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 5:e002713.
   PubMed Web of Science ®Google Scholar
• Thies F, Mills LM, Moir S, Masson LF. 2017. Cardiovascular benefits of lycopene: fantasy or reality? Proc Nutr Soc. 76:122–129.
   PubMed Web of Science ®Google Scholar
• Winter KH, Tuttle LA, Viera AJ. 2013. Hypertension. Prim Care. 40:179–194.
   PubMed Web of Science ®Google Scholar
• Yates CJ, Masuyer G, Schwager SL, Akif M, Sturrock ED, Acharya KR. 2014. Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE). J Biol Chem. 289:1798–1814.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Kawai M. 2010. Synergistic inhibitory effect of angiotensin II receptor blocker and thiazide diuretic on the tissue renin–angiotensin–aldosterone system. J Renin Angiotensin Aldosterone Syst. 11:124–126.
   PubMed Web of Science ®Google Scholar